A Randomized, Open-Label, Multicenter Trial for the Safety and Efficacy of Adult Mesenchymal Stem Cells after Acute Myocardial Infarction

Recent studies suggest that the intracoronary administration of bone marrow (BM)-derived mesenchymal stem cells (MSCs) may improve left ventricular function in patients with acute myocardial infarction (AMI). However, there is still argumentative for the safety and efficacy of MSCs in the AMI settin...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Jun-Won, Lee, Seung-Hwan, Youn, Young-Jin, Ahn, Min-Soo, Kim, Jang-Young, Yoo, Byung-Su, Yoon, Junghan, Kwon, Woocheol, Hong, In-Soo, Lee, Kyounghoon, Kwan, Jun, Park, Keum Soo, Choi, Donghoon, Jang, Yang Soo, Hong, Mun K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Academy of Medical Sciences 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3890472/
https://www.ncbi.nlm.nih.gov/pubmed/24431901
http://dx.doi.org/10.3346/jkms.2014.29.1.23

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3890472/
https://www.ncbi.nlm.nih.gov/pubmed/24431901
http://dx.doi.org/10.3346/jkms.2014.29.1.23

Ejemplares similares